Ascendis Pharma A/S Insider Trading
ASND
Insiders bought 777K and sold $10.8M on the open market.
None of the selling was scheduled in advance under a 10b5-1 plan. EVP & Chief Admin Officer Anni Lotte Kirstine Sonderbjerg Pedersen sold $5.28M on Nov 17, 51% of their stake, outside a plan.
Get an email when ASND's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Nov 17 | Anni Lotte Kirstine Sonderbjerg Pedersen EVP & Chief Admin Officer | SoldNo plan | 20,000 | $263.89 | $5.28M | 51% | Form 4 |
| Sep 8 | Mads Bodenhoff SVP & Pao | SoldNo plan | 3,000 | $270.19 | 811K | 100% | Form 4 |
| Sep 2 | Lars Holtug Director | SoldNo plan | 236 | $264.13 | 62K | 5.6% | Form 4 |
| Aug 14 | Jean Jacques Bienaime Director | Bought 2 parts | 2,000 | $246.33 average | 493K | 222% | Form 4 |
| Jun 2 | Scott Thomas Smith EVP & Chief Financial Officer | Bought | 100 | $219.00 | 22K | 2.3% | Form 4 |
| May 29 | Jean Jacques Bienaime Director | Bought 3 parts | 500 | $223.12 average | 112K | 125% | Form 4 |
| May 29 | Scott Thomas Smith EVP & Chief Financial Officer | Bought | 250 | $223.32 | 56K | 6.2% | Form 4 |
| May 26 | Jean Jacques Bienaime Director | Bought 2 parts | 400 | $237.81 average | 95K | New | Form 4 |
| May 11 | Flemming Steen Jensen See Remarks | SoldNo plan | 19,460 | $238.49 | $4.64M | 100% | Form 4 |
- Nov 17No planAnni Lotte Kirstine Sonderbjerg PedersenEVP & Chief Admin Officer · sold 20,000 at $263.89$5.28M51% of stake
- Sep 8No planMads BodenhoffSVP & Pao · sold 3,000 at $270.19811K100% of stake
- Sep 2No planLars HoltugDirector · sold 236 at $264.1362K5.6% of stake
- Aug 14Jean Jacques BienaimeDirector · bought 2,000 at avg $246.33493K222% of stake
- Jun 2Scott Thomas SmithEVP & Chief Financial Officer · bought 100 at $219.0022K2.3% of stake
- May 29Jean Jacques BienaimeDirector · bought 500 at avg $223.12112K125% of stake
- May 29Scott Thomas SmithEVP & Chief Financial Officer · bought 250 at $223.3256K6.2% of stake
- May 26Jean Jacques BienaimeDirector · bought 400 at avg $237.8195KNew position
- May 11No planFlemming Steen JensenSee Remarks · sold 19,460 at $238.49$4.64M100% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Biotechnology · Pick stocks to compare with ASND
Held by ETFs
ASND is in 59 US ETFs. The largest of them, with ASND's weight in each:
iShares Russell 1000 Growth ETFIWF0.04%of the fund
iShares Russell 1000 Value ETFIWD0.00%of the fund
iShares Russell Mid-Cap ETFIWR0.10%of the fund
Vanguard Russell 1000 Growth ETFVONG0.03%of the fund
iShares Russell 1000 ETFIWB0.02%of the fund
State Street SPDR Portfolio Developed World ex-US ETFSPDW0.04%of the fund
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ASND
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.